BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 944 filers reported holding BAXTER INTL INC in Q1 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,853,598 | -17.2% | 55,414 | +5.7% | 0.01% | -12.5% |
Q1 2024 | $2,239,961 | +12.2% | 52,409 | +1.5% | 0.01% | 0.0% |
Q4 2023 | $1,996,789 | +0.1% | 51,650 | -2.2% | 0.01% | -33.3% |
Q3 2023 | $1,994,031 | -10.6% | 52,836 | +7.9% | 0.01% | -7.7% |
Q2 2023 | $2,230,116 | +21.8% | 48,949 | +8.4% | 0.01% | +8.3% |
Q1 2023 | $1,831,325 | -17.2% | 45,151 | +4.0% | 0.01% | -36.8% |
Q4 2022 | $2,212,710 | +52.3% | 43,412 | +61.0% | 0.02% | +26.7% |
Q3 2022 | $1,453,000 | +85.1% | 26,970 | +120.8% | 0.02% | +114.3% |
Q2 2022 | $785,000 | -33.9% | 12,217 | -20.2% | 0.01% | 0.0% |
Q1 2022 | $1,187,000 | -17.9% | 15,305 | -9.1% | 0.01% | -12.5% |
Q4 2021 | $1,445,000 | +12.7% | 16,830 | +5.6% | 0.01% | -11.1% |
Q3 2021 | $1,282,000 | +53.0% | 15,939 | +53.1% | 0.01% | +80.0% |
Q2 2021 | $838,000 | +4.2% | 10,409 | +9.2% | 0.01% | 0.0% |
Q1 2021 | $804,000 | +18.9% | 9,531 | +13.2% | 0.01% | -28.6% |
Q4 2020 | $676,000 | -8.0% | 8,419 | -7.8% | 0.01% | -22.2% |
Q3 2020 | $735,000 | -25.5% | 9,136 | -20.2% | 0.01% | -35.7% |
Q2 2020 | $986,000 | +212.0% | 11,446 | +193.7% | 0.01% | +7.7% |
Q1 2020 | $316,000 | -72.5% | 3,897 | -71.6% | 0.01% | -27.8% |
Q4 2019 | $1,149,000 | +134.5% | 13,746 | +82.6% | 0.02% | +157.1% |
Q1 2018 | $490,000 | -6.3% | 7,528 | -7.0% | 0.01% | -22.2% |
Q4 2017 | $523,000 | +13.7% | 8,095 | +10.3% | 0.01% | -10.0% |
Q3 2017 | $460,000 | -10.5% | 7,336 | -13.5% | 0.01% | -33.3% |
Q2 2017 | $514,000 | +7.1% | 8,482 | -8.3% | 0.02% | +36.4% |
Q1 2017 | $480,000 | +10.1% | 9,251 | -6.0% | 0.01% | -45.0% |
Q4 2016 | $436,000 | -19.9% | 9,843 | -14.0% | 0.02% | 0.0% |
Q3 2016 | $544,000 | -7.6% | 11,439 | -12.2% | 0.02% | -50.0% |
Q2 2016 | $589,000 | -18.9% | 13,022 | -26.3% | 0.04% | +2.6% |
Q1 2016 | $726,000 | -9.5% | 17,675 | -15.9% | 0.04% | -59.4% |
Q4 2015 | $802,000 | -5.1% | 21,020 | -18.3% | 0.10% | +43.3% |
Q3 2015 | $845,000 | – | 25,725 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |